Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07385690 · ClinicalTrials.gov registry record · NA
Xpan Non-Inferiority Study
A NA study, sponsored by West Virginia University.
- Not yet
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT07385690: Clinical Trial NA study, sponsored by West Virginia University.
NCT07385690 is a NA study that has not yet begun recruiting, run by West Virginia University. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07385690, a NA study, has not yet begun recruiting, sponsored by West Virginia University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
A trocar is a surgical instrument with a sharp point and tube and is used to create endoscopic access in the abdomen or chest where endoscopic instruments can be entered \& used in minimally invasive surgical procedures. Xpan has created an FDA Cleared radially dilating trocar (RDT) that is inserted at 3mm and can be expanded to 5mm or 12mm during surgery. The purpose of this research protocol is to demonstrate that a new FDA Cleared Xpan® radially dilating trocar (RDT) system is at least, just as effective as the existing RDT trocar systems. The procedure will be performed using a radially dilating trocar that is inserted at 3mm and can be expanded to 5mm or 12mm during surgery.
Primary Outcome
Percentage of trocars inserted for use during surgery that need to be adjusted or reinserted during surgical procedure due to slippage and/or displacement.
Interventions
- DEVICE Xpan Trocar System
- DEVICE Standard of Care (Non-expanding Trocar)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-02 |
| Phase | NA |
What is known before NCT07385690 opens enrollment
NCT07385690 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Xpan Trocar System is the first listed.
NCT07385690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07385690 about?
NCT07385690 is a clinical study titled "Xpan Non-Inferiority Study". A trocar is a surgical instrument with a sharp point and tube and is used to create endoscopic access in the abdomen or chest where endoscopic instruments can be entered \& used in minimally invasive surgical procedures. Xpan has created an FDA Cleared radially dilating trocar (RDT) that is inserted...
What is the current status of trial NCT07385690?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2026-02. Estimated completion is 2027-02.
What interventions are being tested in trial NCT07385690?
The interventions under investigation include: Xpan Trocar System (DEVICE), Standard of Care (Non-expanding Trocar) (DEVICE).
Who is sponsoring clinical trial NCT07385690?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07385690's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia